Latest Breaking News On - Executive sekar kathiresan - Page 1 : comparemela.com

Verve Stock Crashes To Record Low After Gene-Editing Drug Causes Side Effects

Verve Stock Crashes To Record Low After Gene-Editing Drug Causes Side Effects
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Sekar kathiresanCenters for diseaseVerve therapeuticsEli lillyChanging genes inside theExecutive sekar kathiresanDisease control

Verve Therapeutics Shares Gain 16% On 4Q Revenue Beat

By Ben Glickman Shares of Verve Therapeutics rose Tuesday after fourth-quarter collaboration revenue came in ahead of expectations. The stock was up 16% to.

United statesSekar kathiresanBen glickmanEli lillyVertex pharmaceuticalsVerve therapeuticsExecutive sekar kathiresanArticle normalBiotechnology servicesScientific research servicesHealthcare life sciencesBusiness consumer servicesBiological therapyMedical research servicesDrug discovery developmentHealthcare provision